Moderna Inc. buy The Goldman Sachs Group, Inc.
Start price
28.01.25
/
50%
€41.85
Target price
28.01.26
€94.88
Performance (%)
-10.12%
End price
29.01.26
€37.62
Summary
This prediction ended on 29.01.26 with a price of €37.62. The price of Moderna Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.12%. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Moderna Inc. | 15.736% | 15.736% | 32.536% |
| iShares Core DAX® | 0.024% | 0.583% | 11.674% |
| iShares Nasdaq 100 | 1.740% | -2.061% | 4.180% |
| iShares Nikkei 225® | 0.428% | 10.487% | 29.994% |
| iShares S&P 500 | 1.329% | 0.140% | 3.333% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Moderna Inc. diskutieren
Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $112.00 to $99.00. They now have a "buy" rating on the stock.
Ratings data for MRNA provided by MarketBeat
In the thread Trading Moderna Inc.
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten